Baidu
map

“掌上药店”下架一错标为OTC的处方药!炔诺酮片仍标为OTC

2019-05-26 向雪妮 南方都市报

近日,南都记者对18家购药App涉嫌违规售卖处方药的情况调查发现,包括“丁香医生”、“360健康”、“掌上药店”、“京东大药房”在内的16家App均销售处方药,部分App购买处方药的流程与网购普通商品无异,无需任何医师或药师审核,即可自助下单购买,而且多家App对处方药进行满减促销。其中,“掌上药店”更是将处方药标为“OTC”(非处方药)来卖。

近日,南都记者对18家购药App涉嫌违规售卖处方药的情况调查发现,包括“丁香医生”、“360健康”、“掌上药店”、“京东大药房”在内的16家App均销售处方药,部分App购买处方药的流程与网购普通商品无异,无需任何医师或药师审核,即可自助下单购买,而且多家App对处方药进行满减促销。其中,“掌上药店”更是将处方药标为“OTC”(非处方药)来卖。

5月23日,南都记者再次登录“掌上药店”App发现,此前报道中提及的一款被错标为“OTC”的处方药已搜索不到,但该App上仍有被标为“OTC”的其他处方药。

5月上旬,南都记者在调查中发现,在“掌上药店”App中搜索“复方甘草口服溶液”后,一家进驻App的“深圳市一通大药房”销售“南国复方甘草口服溶液”。根据国家规定,复方甘草口服溶液属于含特殊药品的复方制剂,必须凭处方销售。然而,这款药品在该App上被标记为“OTC”,摇身一变成为了非处方药。

5月23日下午,南都记者再次在“掌上药店”App搜索“复方甘草口服溶液”,已显示没有该药品。

此前南都记者在调查中发现,“掌上药店”App内进驻商家销售的“南国复方甘草口服溶液”被标记为“OTC”。

除此之外,南都记者在此前调查中还发现,在“掌上药店”App上,必须凭处方销售药品名单中的避孕药“炔诺酮片”,也有被标记为“OTC”的情况。自相矛盾的是,就在同一搜索页面,还显示有标记为“处方药”的“炔诺酮片”。

5月23日下午,南都记者查询发现,在“掌上药店”App上依旧存在“炔诺酮片”被同时标为“OTC”和“处方药”的情况。

南都记者搜索“炔诺酮片”,出现了多条结果。进驻商家“东莞市虎门健发药店”销售的两个不同品牌的“炔诺酮片”,分别被标记为“OTC”和“处方药”。该商家还有“推荐商家”标识。

5月23日下午,南都记者查询发现,在“掌上药店”App上依旧存在“炔诺酮片”被同时标为“OTC”和“处方药”的情况。

选择被标为“OTC”的“康和炔诺酮片”后点击“咨询药师”,页面内弹出与“陆某玲”的对话框,南都记者向其询问为什么同一款药会被同时被标记为“OTC”和“处方药”,其回复称“处方药和非处方药不是药品本质的属性,而是管理上的界定。无论是处方药,还是非处方药都是经过国家药品监督管理部门批准的,其安全性和有效性是有保障的。”并表示被标记为“OTC”的这款“炔诺酮片”可以直接购买。

南都此前报道:

18款购药App测评:9成卖兴奋剂药物!一家售10余种注射液网售处方药乱象调查:多平台敞开卖毒性药还搞促销,帮买家造病情4家购药App下架“敞开卖”的秋水仙碱片!平安好医生展开自查

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1635048, encodeId=efcd1635048ac, content=<a href='/topic/show?id=a262200e41b' target=_blank style='color:#2F92EE;'>#上药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20074, encryptionId=a262200e41b, topicName=上药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b4d22392413, createdName=12498623m100暂无昵称, createdTime=Sun Aug 11 00:08:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080985, encodeId=d681208098535, content=<a href='/topic/show?id=6bd96e0680e' target=_blank style='color:#2F92EE;'>#炔诺酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67068, encryptionId=6bd96e0680e, topicName=炔诺酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Thu Aug 15 23:08:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345996, encodeId=d5d91345996dd, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Tue May 28 13:08:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487476, encodeId=e063148e476d0, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Tue May 28 13:08:00 CST 2019, time=2019-05-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1635048, encodeId=efcd1635048ac, content=<a href='/topic/show?id=a262200e41b' target=_blank style='color:#2F92EE;'>#上药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20074, encryptionId=a262200e41b, topicName=上药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b4d22392413, createdName=12498623m100暂无昵称, createdTime=Sun Aug 11 00:08:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080985, encodeId=d681208098535, content=<a href='/topic/show?id=6bd96e0680e' target=_blank style='color:#2F92EE;'>#炔诺酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67068, encryptionId=6bd96e0680e, topicName=炔诺酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Thu Aug 15 23:08:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345996, encodeId=d5d91345996dd, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Tue May 28 13:08:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487476, encodeId=e063148e476d0, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Tue May 28 13:08:00 CST 2019, time=2019-05-28, status=1, ipAttribution=)]
    2019-08-15 马龙
  3. [GetPortalCommentsPageByObjectIdResponse(id=1635048, encodeId=efcd1635048ac, content=<a href='/topic/show?id=a262200e41b' target=_blank style='color:#2F92EE;'>#上药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20074, encryptionId=a262200e41b, topicName=上药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b4d22392413, createdName=12498623m100暂无昵称, createdTime=Sun Aug 11 00:08:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080985, encodeId=d681208098535, content=<a href='/topic/show?id=6bd96e0680e' target=_blank style='color:#2F92EE;'>#炔诺酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67068, encryptionId=6bd96e0680e, topicName=炔诺酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Thu Aug 15 23:08:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345996, encodeId=d5d91345996dd, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Tue May 28 13:08:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487476, encodeId=e063148e476d0, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Tue May 28 13:08:00 CST 2019, time=2019-05-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1635048, encodeId=efcd1635048ac, content=<a href='/topic/show?id=a262200e41b' target=_blank style='color:#2F92EE;'>#上药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20074, encryptionId=a262200e41b, topicName=上药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b4d22392413, createdName=12498623m100暂无昵称, createdTime=Sun Aug 11 00:08:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080985, encodeId=d681208098535, content=<a href='/topic/show?id=6bd96e0680e' target=_blank style='color:#2F92EE;'>#炔诺酮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67068, encryptionId=6bd96e0680e, topicName=炔诺酮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Thu Aug 15 23:08:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345996, encodeId=d5d91345996dd, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Tue May 28 13:08:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487476, encodeId=e063148e476d0, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Tue May 28 13:08:00 CST 2019, time=2019-05-28, status=1, ipAttribution=)]
    2019-05-28 ymljack

相关资讯

院外处方药市场未来或现爆发式增长

宏观政策上,国家的大方向是强化医药分开政策,支持处方外流,鼓励互联网+,促进医药电商发展。

开始在网上卖药 屈臣氏进军医药电商

屈臣氏在2013年推出了自有电商平台,在该平台上可以搞定你所有需要的日常用品,从洗护用品、彩妆、食品、保健品,再到手机配件、床上用品等应有尽有。接下来屈臣氏可能想要帮你把药品及医疗器械的问题也解决了。

继B证C证之后 医药电商A证也取消审批

今年1月份,国务院宣布取消互联网药品交易B证、C证审批,在医药电商圈子里炸开了锅。而就在昨晚,国务院又公布了新一批取消行政许可的事项,其中就包括备受关注的互联网药品交易服务企业(第三方)(简称医药电商A证)审批。

1药网赴美IPO,医药电商上市潮开启?

8月16日,1药网母公司111集团向美国证券交易委员会(SEC)递交招股书,最高募资2亿美元,交易代码为YI,承销商为摩根大通,花旗和中金。

从中医药引子的神奇功效,谈患者依从性管理的重要价值

关于中医的有效性和科学性一直以来都存在很大的争议,在日常生活和临床学术等各个方面都有不同的说法。

借资本快速扩张 医药零售弱审批、强监管之变

2017年之于医药零售行业,如果简单总结,可概括为政策年、资本年。

Baidu
map
Baidu
map
Baidu
map